PL385697A1 - Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania - Google Patents

Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Info

Publication number: PL385697A1
Authority: PL; Poland
Prior art keywords: methyl; pyridinylamino; thiazolidinedione; ethoxy; phenyl
Prior art date: 2008-07-18

Application number

PL385697A

Other languages

English (en)

Inventor

Michał Chodyński

Andrzej Kutner

Kinga Leszczyńska

Anita Pietraszek

Magdalena Glice

Katarzyna Korczak

Wioleta Maruszak

Original Assignee

Adamed Spółka Z Ograniczoną Odpowiedzialnością

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-18

Filing date

2008-07-18

Publication date

2010-02-01

2008-07-18 Application filed by Adamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Adamed Spółka Z Ograniczoną Odpowiedzialnością

2008-07-18 Priority to PL385697A priority Critical patent/PL385697A1/pl

2010-02-01 Publication of PL385697A1 publication Critical patent/PL385697A1/pl

Links

UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 title 2
YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

PL385697A 2008-07-18 2008-07-18 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania PL385697A1 (pl)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
PL385697A PL385697A1 (pl)	2008-07-18	2008-07-18	Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL385697A PL385697A1 (pl)	2008-07-18	2008-07-18	Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Publications (1)

Publication Number	Publication Date
PL385697A1 true PL385697A1 (pl)	2010-02-01

Family

ID=43012192

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL385697A PL385697A1 (pl)	2008-07-18	2008-07-18	Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Country Status (1)

Country	Link
PL (1)	PL385697A1 (pl)

2008
- 2008-07-18 PL PL385697A patent/PL385697A1/pl not_active Application Discontinuation

Similar Documents

Publication	Publication Date	Title
PL384446A1 (pl)	2009-08-17	Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania
IL223002A0 (en)	2012-12-31	Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
ZA201003902B (en)	2011-02-23	Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide
IL220212A (en)	2015-09-24	Derivatives 5 - [(2-Aminopyrimide-4-Yl) Methylidan] -3,1-Thiazolidine-4,2-Discussion and Pharmaceutical Preparations Containing Them
IL207854A0 (en)	2010-12-30	Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
IL195882A (en)	2016-06-30	Crystalline forms of derivatives of (1 s) –1, 5 – anhydro – 1– c - (3 - ((phenyl) methyl) phenyl) - d -glucitol with amino acids and their use in the treatment of diabetes
IL237820A (en)	2016-12-29	Using a History of 4- (1-Carboxy-Ethylcarbamoyl) -4- (5- [2,1] Ditheolan-3-Il-Pentanoylamino) - Butyric Acid for Drug Preparation
SI2076501T1 (sl)	2016-05-31	Kristalinične oblike 3-(5-(2-florofenil)-1,2,4) oksadiazol-3-il)-benzojske kisline
EP1993934A4 (en)	2011-12-07	PET-CHEWS WITH INTERNAL AND EXTERNAL MATERIALS OF DIFFERENT STIFFNESS
WO2011141933A3 (en)	2012-01-05	Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
AU2008215384A8 (en)	2009-06-11	Crystalline forms of thiazolidinedione compound and its manufacturing method
CY1125531T1 (el)	2026-02-25	Μεθοδος παρασκευης της 5-[[4-[2-[5-(1- υδροξυαιθυλ)-2-πυριδι-νυλ]αιθοξυ]φαινυλ]μεθυλ]- 2,4-θειαζολιδινεδιονη και των αλατων της
IL193670A0 (en)	2009-05-04	A new crystalline form g of (5s)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonyl-methyl]-5-methyl-imidazolidine-2,4-dione (i) and intermediates thereof
BRPI0921596A2 (pt)	2018-03-20	Compostos de 4-[2-(2-fluorofenoximetil) fenil] piperidina
IL279186A (en)	2021-01-31	Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1, 3-thiazolidine-2, 4-dione and their salts
LT3548026T (lt)	2021-05-25	5-[[4-[2-[5-(1-hidroksietil)piridin-2-il]etoksi]fenil]metil]-1,3-tiazolidin-2,4-dionas nealkoholinio kepenų suriebėjimo gydymui
PL385697A1 (pl)	2010-02-01	Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania
IL200959A0 (en)	2010-05-17	Liquid formulations of salts of 4-[2-(4-methylphenylfanyl)phenyl]piperidine
CY2200159T2 (el)	2010-07-28	2-ν-{5-[[4-[2-μεθυλ-2-πυριδινυλαμινο)αιθοξυ]φαινυλ]μεθυλ]-2-4-θειαζολιδινοδιονο} βουτανιοδιοϊκο οξυ, μεθοδοι παρασκευης και συνθεσεις με μηλεϊνικη ροζιγλιταζονη
IL188175A0 (en)	2008-03-20	2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
ZA200809383B (en)	2009-11-25	Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl] amino]methyl]phenyl]-2E-2propenamide
IL212463A0 (en)	2011-06-30	Compositions comprising 4-(2-(5-bromo-4-(l-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
AU2003269483A1 (en)	2005-03-29	Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
WO2008105326A1 (ja)	2008-09-04	２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法
HK40049678A (en)	2021-12-17	Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts

Legal Events

Date	Code	Title	Description
2013-08-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)